Welcome

BioInvent is a research-based pharmaceutical company developing innovative antibody drugs to target diseases with unmet clinical need. The Company's pipeline currently includes product candidates for the treatment of cancer, thrombosis and atherosclerosis.

Meet Us At

17th Annual BioPartnering Europe 11-13 October 2009, London UK
International Pharmaceutical Licensing Symposium 28-30 October 2009, Rome, Italy

Our Pipeline

BioInvent develops antibody-based drugs to tackle conditions where there is a significant need for new treatments. We currently have four antibody therapeutics in development.

Find out more »

Latest Company News

Latest Share Price

Clinical Trials

BioInvent is currently running a number of early-stage clinical trials with several of its products. Click here to find out more »